For people seeking treatment for a migraine in the emergency room, a commonly prescribed opioid called hydromorphone (Dilaudid or Exalgo) doesn't seem to work as well as at least one other medication, a new study finds.
The American Academy of Anti-Aging Medicine (A4M) publishes Longevity Magazine®. A unique feature of The World Health Network, www.worldhealth.net, the A4M's educational website. Longevity Magazine e-Journal is an electronic publication that provides timely and informative news relating to wellness, prevention, and biotech advancements in longevity. Established in 1991 and comprised of 26,000 member physicians, health practitioners, and scientists representing 120 nations worldwide, The American Academy of Anti-Aging Medicine, Inc. (A4M) is a non-profit medical organization dedicated to the advancement of technology to detect, prevent, and treat aging related disease and to promote research into methods to retard and optimize the human aging process. A4M is also dedicated to educating physicians, scientists, and members of the public on anti-aging issues. Although A4M seeks to disseminate information on many types of medical treatments, it does not promote or endorse any specific treatment nor does it sell or endorse any commercial product .
This is a commercial message from A4M, Inc. in full compliance with Federal regulation. Not interested in receiving Longevity Magazine® e-Journal? Click here to be removed from our mailing list.
A4M: 1510 W. Montana Street, Chicago, IL 60614 • Tel: 1-888-997-0112 • Outside USA: 1-561-997-0112
